Federation des caisses Desjardins du Quebec’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,700
Closed -$6.27K 2367
2020
Q3
$6.27K Buy
1,700
+1,525
+871% +$6.44K ﹤0.01% 1806
2020
Q2
$597 Sell
175
-18
-9% -$40 ﹤0.01% 2026
2020
Q1
$259 Hold
193
﹤0.01% 2156
2019
Q4
$284 Sell
193
-728
-79% -$1.22K ﹤0.01% 2256
2019
Q3
$1.93K Sell
921
-164
-15% -$335 ﹤0.01% 2091
2019
Q2
$2.65K Sell
1,085
-9
-0.8% -$20 ﹤0.01% 2082
2019
Q1
$2.85K Hold
1,094
﹤0.01% 1891
2018
Q4
$3.29K Sell
1,094
-19
-2% -$64 ﹤0.01% 1845
2018
Q3
$3.85K Sell
1,113
-3,000
-73% -$15.9K ﹤0.01% 1929
2018
Q2
$19.3K Buy
4,113
+3,000
+270% +$11.4K ﹤0.01% 1575
2018
Q1
$3.53K Sell
1,113
-526
-32% -$2.12K ﹤0.01% 1936
2017
Q4
$8.03K Sell
1,639
-2,200
-57% -$12.8K ﹤0.01% 1760
2017
Q3
$26.3K Sell
3,839
-2,920
-43% -$18.4K ﹤0.01% 1474
2017
Q2
$44.5K Buy
+6,759
New +$47.4K ﹤0.01% 1402

Other funds holding OPK

Federation des caisses Desjardins du Quebec's OPK Position: Q4 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Opko Health (OPK) in Q4 2020, closing a stake of 1,700 shares — an estimated $6.27K sold.

Federation des caisses Desjardins du Quebec first reported a position in OPK in Q2 2017 and held it in 14 quarters. The position peaked at $44.5K in Q2 2017. 239 funds tracked by Wall St. Rank hold OPK as of Q4 2020.

  • Federation des caisses Desjardins du Quebec reported no remaining Opko Health position as of Q4 2020 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 1,700 Opko Health shares in Q4 2020, an estimated $6.27K.
  • Federation des caisses Desjardins du Quebec first reported a position in Opko Health in Q2 2017 and held it in 14 quarters.
  • Federation des caisses Desjardins du Quebec's Opko Health position peaked at $44.5K in Q2 2017.
  • 239 funds tracked by Wall St. Rank held Opko Health as of Q4 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2020, filed 30 Aug 2024.